Nuala Moran. Show Affiliations »
Abstract
Mesh： See more » AdultAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useBiotechnology/trendsBreast Neoplasms/drug therapyCost-Benefit AnalysisDecision Making, OrganizationalDrug Approval/statistics & numerical dataFemaleGovernment AgenciesHumansNational Health ProgramsReceptor, ErbB-2/metabolismTechnology Assessment, Biomedical/methodsTechnology Assessment, Biomedical/statistics & numerical dataTrastuzumabUnited Kingdom
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsERBB2 protein, humanReceptor, ErbB-2Trastuzumab
Year: 2009 PMID： 19270658 DOI： 10.1038/nbt0309-215
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908